TMB - a histology-agnostic predictor of the efficacy of ICIs?

Nat Rev Clin Oncol. 2020 Dec;17(12):718. doi: 10.1038/s41571-020-00438-0.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized*
  • Biomarkers, Tumor / genetics
  • Humans
  • Neoplasms* / drug therapy
  • Prospective Studies

Substances

  • Antibodies, Monoclonal, Humanized
  • Biomarkers, Tumor
  • pembrolizumab